Cresset Asset Management, LLC Innoviva, Inc. Transaction History

Cresset Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$15.39 - $20.25 $212,812 - $280,017	-13,828 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$15.91 - $18.72 $220,003 - $258,860	13,828 New	13,828 $238,000
Q2 2019 Aug 12, 2019	SELL	$13.1 - $14.95 $353 - $403	-27 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$13.69 - $20.06 $1,013 - $1,484	-74 Reduced 73.27%	27 $0
Q4 2018 May 21, 2019	BUY	$13.96 - $18.26 $1,409 - $1,844	101 New	101 $2,000

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.28B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cresset Asset Management, LLC with notifications on news.